Intest Res Search

CLOSE


‘Intestinal Research’ (Intest Res) is the joint official publication of the Asian Organization for Crohn's and Colitis (AOCC), Chinese Society of IBD (CSIBD), Japanese Society for IBD (JSIBD), Korean Association for the Study of Intestinal Diseases (KASID), Taiwan Society of IBD (TSIBD) and Colitis Crohn's Foundation (India) (CCF, india).
The aim of the Journal is to provide broad and in-depth analysis of intestinal diseases, especially inflammatory bowel disease, which shows increasing tendency and significance.As a Journal specialized in clinical and translational research in gastroenterology, it encompasses multiple aspects of diseases originated from the small and large intestines.

Review

December 1, 2020


Gut microbiome and checkpoint inhibitor colitis
Kanika Sehgal, Sahil Khanna
Intest Res. 2021;19(4):360-364.

Review

November 25, 2020


Crohn’s disease at radiological imaging: focus on techniques and intestinal tract
Giuseppe Cicero, Silvio Mazziotti
Intest Res. 2021;19(4):365-378.

Review

November 6, 2020


An overview of the gut side of the SARS-CoV-2 infection
Bruna Barbosa da Luz, Natalia Mulinari Turin de Oliveira, Isabella Wzorek França dos Santos, et al.
Intest Res. 2021;19(4):379-385.

Original Article

December 1, 2020


Efficacy and safety of ustekinumab in East Asian patients with moderately to severely active ulcerative colitis: a subpopulation analysis of global phase 3 induction and maintenance studies (UNIFI)
Tadakazu Hisamatsu, Hyo Jong Kim, Satoshi Motoya, et al.
Intest Res. 2021;19(4):386-397.

Original Article

November 20, 2020


Very early onset inflammatory bowel disease in a South Asian country where inflammatory bowel disease is emerging: a distinct clinical phenotype from later onset disease
Rupa Banerjee, Partha Pal, Zaheer Nabi, et al.
Intest Res. 2021;19(4):398-407.

Original Article

November 20, 2020


Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn’s disease: 3-year results from a real-world study
Tadakazu Hisamatsu, Yasuo Suzuki, Mariko Kobayashi, et al.
Intest Res. 2021;19(4):408-418.

Original Article

November 10, 2020


Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study
Haruhiko Ogata, Takashi Hagiwara, Takeshi Kawaberi, et al.
Intest Res. 2021;19(4):419-429.

Original Article

November 9, 2020


Clinical characteristics of inflammatory bowel disease patients with immunoglobulin A nephropathy
Ryohei Hayashi, Yoshitaka Ueno, Shinji Tanaka, et al.
Intest Res. 2021;19(4):430-437.

Original Article

November 6, 2020


High mucosal cytomegalovirus DNA helps predict adverse short-term outcome in acute severe ulcerative colitis
Saransh Jain, Divya Namdeo, Pabitra Sahu, et al.
Intest Res. 2021;19(4):438-447.

Original Article

August 18, 2020


Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderately to severely active ulcerative colitis
Taku Kobayashi, Hiroaki Ito, Toshifumi Ashida, et al.
Intest Res. 2021;19(4):448-460.

Original Article

August 18, 2020


Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
Eirini Theodoraki, Eleni Orfanoudaki, Kalliopi Foteinogiannopoulou, et al.
Intest Res. 2021;19(4):461-467.

This archive contains links to the full-text of all issues of Intest Res.

All issues

Vol. 19
2021
v.19(1)
Jan 2021
v.19(2)
Apr 2021
v.19(3)
Jul 2021
v.19(4)
Oct 2021
Vol. 18
2020
v.18(1)
Jan 2020
v.18(2)
Apr 2020
v.18(3)
Jul 2020
v.18(4)
Oct 2020
Vol. 17
2019
v.17(1)
Jan 2019
v.17(2)
Apr 2019
v.17(3)
Jul 2019
v.17(4)
Oct 2019
Vol. 16
2018
v.16(1)
Jan 2018
v.16(2)
Apr 2018
v.16(3)
Jul 2018
v.16(4)
Oct 2018
Vol. 15
2017
v.15(1)
Jan 2017
v.15(2)
Apr 2017
v.15(3)
Jul 2017
v.15(4)
Oct 2017
Vol. 14
2016
v.14(1)
Jan 2016
v.14(2)
Apr 2016
v.14(3)
Jul 2016
v.14(4)
Oct 2016
Vol. 13
2015
v.13(1)
Jan 2015
v.13(2)
Apr 2015
v.13(3)
Jul 2015
v.13(4)
Oct 2015
Vol. 12
2014
v.12(1)
Jan 2014
v.12(2)
Apr 2014
v.12(3)
Jul 2014
v.12(4)
Oct 2014
Vol. 11
2013
v.11(1)
Jan 2013
v.11(2)
Apr 2013
v.11(3)
Jul 2013
v.11(4)
Oct 2013
Vol. 10
2012
v.10(1)
Feb 2012
v.10(2)
Apr 2012
v.10(3)
Jul 2012
v.10(4)
Oct 2012
Vol. 9
2011
v.9(1)
Apr 2011
v.9(2)
Aug 2011
v.9(3)
Dec 2011
Vol. 8
2010
v.8(1)
Jun 2010
v.8(2)
Dec 2010
Vol. 7
2009
v.7(1)
Jun 2009
v.7(2)
Dec 2009
Vol. 6
2008
v.6(1)
Jun 2008
v.6(2)
Dec 2008
Vol. 5
2007
v.5(1)
Jun 2007
v.5(2)
Dec 2007
Vol. 4
2006
v.4(1)
Jun 2006
v.4(2)
Dec 2006
Vol. 3
2005
v.3(1)
Jun 2005
v.3(2)
Dec 2005
Vol. 2
2004
v.2(1)
Apr 2004
v.2(2)
Dec 2004
Vol. 1
2003
v.1(1)
May 2003
v.1(2)
Nov 2003
  • SCImago Journal & Country Rank
  • AOCC 2018
  • CSIBD
  • JSIBD
  • kasid
  • TSIBD
  • CCF
  • PubMed Central
  • PubMed
  • KoreaMed
  • KoMCI
  • Scopus
  • Directory of Open Access Journals (DOAJ)
  • GoogleScholar
  • EBSCO
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID
  • COPE
  • KOFST
  • TrendMD

ABOUT
ARTICLE & TOPICS
Article Category

Browse all articles >

TOPICS

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
Room 305, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145    Fax: +82-2-957-6146    E-mail: thekasid@irjournal.org                

Copyright © 2022 by Korean Association for the Study of Intestinal Diseases.

Developed in M2PI

Close layer
prev next
Close layer
prev next